Boccardo Francesco, Fulcheri Ezio, Villa Giuseppe, Molinari Lidia, Campisi Corrado, Dessalvi Sara, Murdaca Giuseppe, Campisi Caterina, Santi Pier Luigi, Parodi Aurora, Puppo Francesco, Campisi Corradino
Unit of Lymphatic Surgery, Department of Surgery, IRCCS S. Martino University Hospital-IST, Genoa, Italy.
Ann Plast Surg. 2013 Aug;71(2):191-5. doi: 10.1097/SAP.0b013e31824f20d4.
This study aimed to report new clinical approaches to the treatment of lymphatic disorders by microsurgical techniques based on histological and immunohistochemical findings. The authors' wide clinical experience in the treatment of patients with peripheral lymphedema by microsurgical techniques is reported. Microsurgical methods included derivative lymphatic-venous anastomoses and lymphatic reconstruction by interpositioned vein grafted shunts. In all patients, lymphatic and lymph nodal tissues were sent for histological assessment, together with specimen of the interstitial matrix. Diagnostic investigations consisted in venous duplex scan and lymphoscintigraphy. Results were assessed clinically by volumetry performed preoperatively and postoperatively at 3 to 6 months and at 1, 3, and 5 years. The outcome obtained in treating lymphedemas at different stages was analyzed for volume reduction, stability of results with time, reduction of dermatolymphangioadenitis attacks, necessity of wearing elastic supports, and use of conservative measures postoperatively. Microsurgical lymphatic derivative and reconstructive techniques allow bringing about positive results in the treatment of peripheral lymphedema, above all in early stages when tissular changes are slight and allow almost a complete restore of lymphatic drainage.
本研究旨在根据组织学和免疫组化结果报告通过显微外科技术治疗淋巴系统疾病的新临床方法。报告了作者在通过显微外科技术治疗外周性淋巴水肿患者方面的广泛临床经验。显微外科方法包括衍生性淋巴管-静脉吻合术以及通过插入静脉移植分流术进行淋巴重建。所有患者的淋巴和淋巴结组织均与间质基质标本一起送去进行组织学评估。诊断性检查包括静脉双功扫描和淋巴闪烁显像。通过术前以及术后3至6个月、1年、3年和5年进行的体积测量对结果进行临床评估。分析了在治疗不同阶段淋巴水肿时所获得的结果,包括体积减小、结果随时间的稳定性、皮肤淋巴管炎发作次数的减少、穿戴弹性支撑物的必要性以及术后保守措施的使用情况。显微外科淋巴衍生和重建技术在外周性淋巴水肿的治疗中能够带来积极效果,尤其是在组织变化轻微且几乎能实现淋巴引流完全恢复的早期阶段。